摘要
Non-small cell lung cancer (NSCLC) has a high morbidity and mortality, and it is imperative to explore the latent pathogenesis mechanism of NSCLC progression to find potential prognostic biomarkers and therapeutic targets. The present study aimed to explore the biological function of circSHKBP1 in NSCLC. circSHKBP1 was found to be upregulated in NSCLC tissues and cell lines and was enriched in exosomes derived from NSCLC cells. Exosomal circSHKBP1 enhanced the proliferation, migration, invasion, and stemness of NSCLC cells. miRNA-1294 was identified as a target for circSHKBP1, and circSHKBP1 upregulated PKM2 expression by sponging miR-1294. Exosomal circSHKBP1 regulated glycolysis through PKM2 in a HIF-1 alpha-dependent manner in NSCLC cells and promoted M2 polarization and macrophage recruitment. Moreover, exosomal circSHKBP1 promoted NSCLC cell growth, metastasis, and M2 infiltration in vivo. Thus, exosomal circSHKBP1 participated in the progression of NSCLC via the miR-1294/PKM2 axis. circSHKBP1 may be potential biomarker for the diagnosis and treatment of NSCLC.
学科与关键词
- Circ_0047921 acts as the sponge of miR-1287-5p to stimulate lung cancer progression by regulating proliferation, migration, invasion, and glycolysis of lung cancer cellsXiao, Yuehua; Gu, Shequn*; Yao, Wenxiu; Qin, Ling; Luo, JihuiWorld Journal of Surgical Oncology, 2022, 20(1): 108.被引 3
- Bone Marrow Mesenchymal Stem Cells (BMSCs)-Originated miR-1298 Impedes the Aggressiveness of Non-Small Cell Lung Cancer by Hindering the Chemokine Receptor 4 (CXCR4)-Induced Epithelial-Mesenchymal Transition (EMT) ProcessNie, Guangjie; Wei, Xiaoqun; Ye, Jun*Journal of Biomaterials and Tissue Engineering, 2022, 12(6): 1194-1201.
- CircFOXP1: A novel serum diagnostic biomarker for non-small cell lung cancerLuo, Yirong; Zhang, Qichao; Lv, Bo; Shang, Yanyan; Li, Juan; Yang, Lina; Yu, Zhiwu; Luo, Kai; Deng, Xiaoyan; Min, Ling; Zhu, Ting*INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2022, 37(1): 58-65.被引 8
